177 results on '"Van Laere, Koen"'
Search Results
2. Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [11C]CHDI-00485180-R and [11C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtin
3. Long-term test-retest of cerebral [18F]MK-6240 binding and longitudinal evaluation of extracerebral tracer uptake in healthy controls and amnestic MCI patients
4. Not all black colons on [18F]FDG PET are due to metformin
5. Classification of 18F-Flutemetamol scans in cognitively normal older adults using machine learning trained with neuropathology as ground truth
6. Regional glucose metabolic decreases with ageing are associated with microstructural white matter changes: a simultaneous PET/MR study
7. Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [18F]JNJ42259152 PET study in rats
8. Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study
9. Clinical validation of the novel HDAC6 radiotracer [18F]EKZ-001 in the human brain
10. [18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients
11. Correction to: Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [18F]JNJ42259152 PET study in rats
12. Direct prospective comparison of 18F-FDG PET and arterial spin labelling MR using simultaneous PET/MR in patients referred for diagnosis of dementia
13. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
14. Binding of [18F]AV1451 in post mortem brain slices of semantic variant primary progressive aphasia patients
15. Quantification and discriminative power of 18F-FE-PE2I PET in patients with Parkinson’s disease
16. Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson’s disease
17. Improved resolution and sensitivity of [18F]MFBG PET compared with [123I]MIBG SPECT in a patient with a norepinephrine transporter–expressing tumour
18. [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers
19. Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue
20. Distinct [18F]THK5351 binding patterns in primary progressive aphasia variants
21. Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders
22. Al18F-NOTA-octreotide: first comparison with 68Ga-DOTATATE in a neuroendocrine tumour patient
23. [18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patients
24. Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks
25. Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease
26. Implementation of the European multicentre database of healthy controls for [123I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes
27. Reduction in camera-specific variability in [123I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls
28. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [18F]DPA-714 PET
29. Amyloid imaging in cognitively normal older adults: comparison between 18F-flutemetamol and 11C-Pittsburgh compound B
30. Highlights lecture EANM 2014: “Gimme gimme gimme those nuclear Super Troupers”
31. Extrastriatal binding of [123I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls
32. Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa
33. Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study
34. Regional glucose metabolic decreases with ageing are associated with microstructural white matter changes: a simultaneous PET/MR study
35. Fibrous dysplasia mimicking bone metastasis on 68GA-PSMA PET/MRI
36. Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database
37. Human biodistribution and dosimetry of 18F-JNJ42259152, a radioligand for phosphodiesterase 10A imaging
38. A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease
39. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis
40. Small-animal PET imaging of the type 1 and type 2 cannabinoid receptors in a photothrombotic stroke model
41. Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [18F]JNJ42259152 PET study in rats
42. Preclinical evaluation and quantification of [18F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain
43. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease
44. Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism
45. The effect of anaesthesia on [18F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain
46. Anatomy-based reconstruction of FDG-PET images with implicit partial volume correction improves detection of hypometabolic regions in patients with epilepsy due to focal cortical dysplasia diagnosed on MRI
47. Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain
48. EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2
49. EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2
50. EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.